- Mikart has opened a new executive headquarters in Northwest Atlanta to support growth and operations.
- The company is expanding its oral solid dosage manufacturing, increasing bottling capacity by more than 50% with completion expected in Q4 2026.
Mikart announced the opening of its new executive headquarters in Northwest Atlanta, marking a step in its ongoing expansion strategy. The new facility is designed to centralize operations, support team growth, and strengthen the company’s presence in the Atlanta region.
The relocation, originally announced in September 2025, establishes a modern headquarters intended to improve collaboration and accommodate future business expansion. The site will serve as the company’s primary executive base as it continues to scale its contract development and manufacturing organization (CDMO) operations.
Alongside the headquarters move, Mikart is advancing a manufacturing expansion focused on oral solid dosage (OSD) bottling and downstream packaging. The project is expected to increase bottling capacity by more than 50%, supporting growing partner demand and expanding contract manufacturing capabilities. The expansion is scheduled for completion with operational start-up in the fourth quarter of 2026.
“Our new headquarters provides the space and infrastructure needed to support our growing team and evolving business while reinforcing our commitment to operational excellence and innovation.”
Michael Kallelis, Chief Executive Officer of Mikart
Mikart stated that the combined investment in headquarters and manufacturing expansion is intended to improve operational resilience and enable scalable growth. The company’s headquarters and manufacturing operations will remain based in Atlanta, Georgia, supporting its long-term presence in the region.
